Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update to its business involving Pfizer and that CEO Heather Bresch is resigning.
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Doctors and drug counselors have long warned the public about the dangers of drinking alcohol while taking the club drug MDMA, also known as Molly or Ecstasy. The combination, they say, can induce severe…
About 100 Americans are drowned every year trying to escape from rip currents. Here's how to spot and how to get out of a rip current.
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Intra-Cellular saw its shares dip on Wednesday after the firm announced that the FDA has canceled a meeting scheduled for July 31 to discuss the New Drug Application for lumateperone for the treatment of…
Jounce Therapeutics shares jumped on Wednesday after the company announced an update on its strategic collaboration with Celgene. This collaboration was originally established in July of 2016.
Acadia Pharmaceuticals shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients.
Biogen shares rose after itreleased better than expected second-quarter financial results before the markets opened on Tuesday.
Professional athletes generally are healthier than most people. New research shows that some of the habits of professional baseball players could make them live longer, on average, than the rest of the male population.
It’s well-known that clogged arteries — in which blood flow is constricted by build-ups of coronary artery calcium (CAC) or plaque — is a risk factor for heart disease. But doctors and the general…
PetMed shares retreated after it reported disappointing fiscal first-quarter financial results before the markets opened on Monday.
Cancer research funds apparently are not linked to whether a type of cancer is deadly. As a matter of fact, often the deadliest cancers get the least research funding from nonprofit research organizations.
Leading health care data and analytics technology and services provider Health Catalyst aims to price 6 million shares for an initial public offering is valued up to more than $158 million.
